Crown Bioscience provides Translational Platforms focused on fast-tracking candidates to identify biomarkers and patient responders based on the pharmacological response of human surrogate models. Power your Drug Discovery using the world’s largest commercial collection of well-characterised PDX in passage plus a curated, searchable database of patient, genotypic and phenotypic data as well as pharmacological response.
The Jackson Laboratory is a leading provider of cancer mouse models and In Vivo oncology services and a National Cancer Institute-designated Cancer Center. Drawing on decades of mouse-based oncology research experience, we provide capabilities around model selection and husbandry and customizable oncology studies to help clients and researchers evaluate novel anti-cancer therapies.
Champions Oncology was founded by renowned specialists in the field of cancer diagnosis, treatment, and research. The team is comprised of seasoned oncology professionals passionately dedicated to working to accelerate oncology drug development, improve treatment outcomes and extend lives. Our core platform, the Champions TumorGraft™ offers an enhanced xenograft mouse avatar model for growing and testing human tumors.
Miltenyi Biotec’s mission is to improve scientific understanding and medical progress. We provide products and services that advance biomedical research and cellular therapy. Honoring this mission drives our commitment to support the translation of basic research into therapy in the areas of immunology, cancer, neuroscience and stem cell biology. We innovate products that address sample preparation, separation of cells and their analysis, and that advance the concept of cellular therapy.
Envigo is an international CRO offering a comprehensive range of development services to pharmaceutical and biopharmaceutical companies. We help our customers develop safe and effective new compounds. Our Research Models and Services operating group provides high-quality research models and lab animal diets with support services worldwide.
Mitra Biotech is a global leader in advancing personalized cancer treatment and empowering drug development & discovery. Our phenotypic CANscript platform delivers powerful insight for our biopharma partners. Because CANscript conserves the native tumor microenvironment and delivers 1:1 clinical correlation… Read More